Proteolytic resistance conferred to fibrinogen by von Willebrand factor

Thrombosis and Haemostasis

Volumn 103, Issue 2, 2010, Pages 291-298

  Tanka Salamon, Anna ^a   Kolev, Krasimir ^a   Machovich, Raymund ^a   Komorowicz, Erzsebet ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Fibrinogen; Fibrinolysis; Plasmin; Thrombolysis; Von willebrand factor

Indexed keywords

FIBRINOGEN; PLASMINOGEN; VON WILLEBRAND FACTOR;

ARTICLE; BINDING SITE; BLOOD LEVEL; CALCULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOLUTION; HUMAN; KINETICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; THROMBOCYTE;

BLOOD COAGULATION; CELL ADHESION; FIBRINOGEN; FIBRINOLYSIN; FIBRINOLYSIS; HUMANS; KINETICS; PEPTIDE HYDROLASES; PROTEIN BINDING; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 75749128645     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-07-0420     Document Type: Article

References (37)

1. Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemostasis 2003; 1: 1335-1342.
2. Ruggeri ZM. Von Willebrand factor: Looking back and looking forward. Thromb Haemost 2007; 98: 55-62.
3. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-297.
4. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998; 94: 657-666.
5. Ruggeri ZM, Savage B. Platelet-vessel wall interactions in flowing blood. In: Hemostasis and thrombosis. Basic principles and clinical practice. 5th ed. Lippincott Williams & Wilkins 2006; pp. 723-735.
6. Weiss HJ, Turitto VT, Baumgartner HR. Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects. J Clin Invest 1986; 78: 1072-1082.
7. McBane RD II, Ford MAP, Karnicki K, et al. Fibrinogen, fibrin and crosslinking in aging arterial thrombi. Thromb Haemost 2000; 84: 83-87.
8. Loscalzo J, Inbal A, Handin RI. von Willebrand protein facilitates platelet incorporation in polymerizing fibrin. J Clin Invest 1986; 78: 1112-1119.
9. Goto S, Ikeda Y, Saldivar E, Ruggeri ZM. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 1998; 101: 479-486.
10. Ruggeri ZM, Dent JA, Saldivar E. Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood 1999; 94: 172-178.
11. Tsuji S, Sugimoto M, Miyata S, et al. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow. Blood 1999; 94: 968-975.
12. Gelfand EV, Cannon CP. Acute coronary syndromes. In: Hemostasis and thrombosis. Basic principles and clinical practice. 5th ed. Lippincott Williams and Wilkins 2006; 1387-1404.
13. Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991; 78: 3114-3124.
14. Machovich R, Owen WG. The elastase-mediated pathway of fibrinolysis. Blood Coagul Fibrinolysis 1990; 1: 79-90.
15. Kolev K, Tenekedjiev K, Komorowicz E, et al. Functional evaluation of the structural features of proteases and their substrate in fibrin surface degradation. J Biol Chem 1997; 272: 13666-13675.
16. Kolev K, Komorowicz E, Owen WG, et al. Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neutrophil leukocyte elastase and cathepsin G. Thromb Haemost 1996; 75: 140-146.
17. Komorowicz E, Kolev K, Lerant I, et al. Flow rate-modulated dissolution of fibrin with clot-embedded and circulating proteases. Circ Res 1998; 82: 1102-1108.
18. Komorowicz E, Kolev K, Machovich R. Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors. Biochemistry 1998; 37: 9112-9118.
19. Kolev K, Machovich R. Molecular and cellular modulation of fibrinolysis. Thromb Haemost 2003; 89: 610-621.
20. Tanka-Salamon A, Tenekedjiev K, Machovich R, et al. Suppressed catalytic efficiency of plasmin in the presence of long-chain fatty acids. Identification of kinetic parameters from continuous enzymatic assay with Monte Carlo simulation. FEBS Journal 2008; 275: 1274-1282.
21. Gombas J, Tanka-Salamon A, Skopal J, et al. Modulation of fibrinolysis by the combined action of phospholipids and immunoglobulins. Blood Coagul Fibrinolysis 2008; 19: 82-88.
22. Bonnefoy A, Legrand C. Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase. Thromb Res 2000; 98: 323-332.
23. Lundblad RL, Kingdon HS, Mann KG. Thrombin. Meth Enzymol 1976; 45: 156-76.
24. Deutsch DG, Mertz ET. Plasminogen purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096.
25. Machovich R, Owen WG. An elastase-dependent pathway of plasminogen activation. Biochemistry 1989; 28: 4517-4512.
26. Wu HL, Shi GY, Bender ML. Preparation and purification of microplasmin. Proc Natl Acad Sci USA 1987; 84: 8292-8295.
27. Kolev K, Léránt I, Tenekedjiev K, et al. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin and miniplasmin by plasma protease inhibitors. J Biol Chem 1994; 269: 17030-17034.
28. Inglese J, Samama P, Patel S, et al. Chemokine receptor-ligand interactions measured using time-resolved fluorescence. Biochemistry 1998; 37: 2372-2377.
29. Handl HL, Vagner J, Yamamura HI, et al. Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions. Anal Biochem 2004; 330: 242-250.
30. Thorell L, Blomback B. Purification of the factor VIII complex. Thromb Res 1984; 35: 431-450.
31. Kolev K, Tenekedjiev K, Ajtai K, et al. Myosin: a non-covalent stabilizer of fibrin in the process of clot dissolution. Blood 2003; 101: 4380-4386.
32. Johnson ML, Frasier SG. Nonlinear least-squares analysis. Meth Enzymol 1985; 117: 301-342.
33. Fleury V, Anglés-Cano E. Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines. Biochemistry 1991; 30: 7630-7638.
34. Bok RA, Mangel WF. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin. Biochemistry 1985; 24: 3279-3286.
35. Nogami K, Nishiya K, Saenko EL, et al. Identification of a plasmin-interactive site within the A2 domain of the factor VIII heavy chain. Biochim Biophys Acta 2008; 1784: 753-763.
36. Nogami K, Nishiya K, Saenko EL, et al. Identification of plasmin-interactive sites in the light chain of factor VIII responsible for proteolytic cleavage at Lys36. J Biol Chem 2009; 284: 6934-6945.
37. Federici AB, Berkowitz SD, Zimmerman TS, et al. Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction. Blood 1992; 79: 38-44.